List of Tables
    Table 1. Targeted Drugs for Breast Cancer Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Targeted Drugs for Breast Cancer Market Trends
    Table 3. Targeted Drugs for Breast Cancer Market Drivers
    Table 4. Targeted Drugs for Breast Cancer Market Challenges
    Table 5. Targeted Drugs for Breast Cancer Market Restraints
    Table 6. Global Targeted Drugs for Breast Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Targeted Drugs for Breast Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Targeted Drugs for Breast Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Targeted Drugs for Breast Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Targeted Drugs for Breast Cancer Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Targeted Drugs for Breast Cancer Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Targeted Drugs for Breast Cancer Revenue Share by Player, 2017-2022
    Table 13. Global Targeted Drugs for Breast Cancer Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Targeted Drugs for Breast Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Breast Cancer as of 2021)
    Table 15. Top Players of Targeted Drugs for Breast Cancer in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Targeted Drugs for Breast Cancer Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Targeted Drugs for Breast Cancer Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Targeted Drugs for Breast Cancer Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Targeted Drugs for Breast Cancer Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Targeted Drugs for Breast Cancer Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Targeted Drugs for Breast Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Targeted Drugs for Breast Cancer Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Targeted Drugs for Breast Cancer Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Targeted Drugs for Breast Cancer Product
    Table 33. Roche Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Teva Company Details
    Table 36. Teva Business Overview
    Table 37. Teva Targeted Drugs for Breast Cancer Product
    Table 38. Teva Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 39. Teva Recent Development
    Table 40. Mylan Company Details
    Table 41. Mylan Business Overview
    Table 42. Mylan Targeted Drugs for Breast Cancer Product
    Table 43. Mylan Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 44. Mylan Recent Development
    Table 45. Hikma Company Details
    Table 46. Hikma Business Overview
    Table 47. Hikma Targeted Drugs for Breast Cancer Product
    Table 48. Hikma Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 49. Hikma Recent Development
    Table 50. Hengrui Medicine Company Details
    Table 51. Hengrui Medicine Business Overview
    Table 52. Hengrui Medicine Targeted Drugs for Breast Cancer Product
    Table 53. Hengrui Medicine Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 54. Hengrui Medicine Recent Development
    Table 55. Cipla Company Details
    Table 56. Cipla Business Overview
    Table 57. Cipla Targeted Drugs for Breast Cancer Product
    Table 58. Cipla Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 59. Cipla Recent Development
    Table 60. Reliance Group Company Details
    Table 61. Reliance Group Business Overview
    Table 62. Reliance Group Targeted Drugs for Breast Cancer Product
    Table 63. Reliance Group Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 64. Reliance Group Recent Development
    Table 65. Hetero Company Details
    Table 66. Hetero Business Overview
    Table 67. Hetero Targeted Drugs for Breast Cancer Product
    Table 68. Hetero Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 69. Hetero Recent Development
    Table 70. Pfizer Company Details
    Table 71. Pfizer Business Overview
    Table 72. Pfizer Targeted Drugs for Breast Cancer Product
    Table 73. Pfizer Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 74. Pfizer Recent Development
    Table 75. Eli Lilly Company Details
    Table 76. Eli Lilly Business Overview
    Table 77. Eli Lilly Targeted Drugs for Breast Cancer Product
    Table 78. Eli Lilly Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 79. Eli Lilly Recent Development
    Table 80. Novartis Company Details
    Table 81. Novartis Business Overview
    Table 82. Novartis Targeted Drugs for Breast Cancer Product
    Table 83. Novartis Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 84. Novartis Recent Development
    Table 85. CANbridge Company Details
    Table 86. CANbridge Business Overview
    Table 87. CANbridge Targeted Drugs for Breast Cancer Product
    Table 88. CANbridge Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 89. CANbridge Recent Development
    Table 90. Puma Biotechnology Company Details
    Table 91. Puma Biotechnology Business Overview
    Table 92. Puma Biotechnology Targeted Drugs for Breast Cancer Product
    Table 93. Puma Biotechnology Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 94. Puma Biotechnology Recent Development
    Table 95. AstraZeneca Company Details
    Table 96. AstraZeneca Business Overview
    Table 97. AstraZeneca Targeted Drugs for Breast Cancer Product
    Table 98. AstraZeneca Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 99. AstraZeneca Recent Development
    Table 100. Chugai Pharmaceutical Company Details
    Table 101. Chugai Pharmaceutical Business Overview
    Table 102. Chugai Pharmaceutical Targeted Drugs for Breast Cancer Product
    Table 103. Chugai Pharmaceutical Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 104. Chugai Pharmaceutical Recent Development
    Table 105. Eisai Company Details
    Table 106. Eisai Business Overview
    Table 107. Eisai Targeted Drugs for Breast Cancer Product
    Table 108. Eisai Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 109. Eisai Recent Development
    Table 110. GlaxoSmithKline Company Details
    Table 111. GlaxoSmithKline Business Overview
    Table 112. GlaxoSmithKline Targeted Drugs for Breast Cancer Product
    Table 113. GlaxoSmithKline Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 114. GlaxoSmithKline Recent Development
    Table 115. Bristol-Myers Squibb Company Details
    Table 116. Bristol-Myers Squibb Business Overview
    Table 117. Bristol-Myers Squibb Targeted Drugs for Breast Cancer Product
    Table 118. Bristol-Myers Squibb Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 119. Bristol-Myers Squibb Recent Development
    Table 120. Otsuka Pharmaceutical Company Details
    Table 121. Otsuka Pharmaceutical Business Overview
    Table 122. Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Product
    Table 123. Otsuka Pharmaceutical Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 124. Otsuka Pharmaceutical Recent Development
    Table 125. Merck Company Details
    Table 126. Merck Business Overview
    Table 127. Merck Targeted Drugs for Breast Cancer Product
    Table 128. Merck Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 129. Merck Recent Development
    Table 130. BioMarin Company Details
    Table 131. BioMarin Business Overview
    Table 132. BioMarin Targeted Drugs for Breast Cancer Product
    Table 133. BioMarin Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 134. BioMarin Recent Development
    Table 135. Hengrui Pharmaceutical Company Details
    Table 136. Hengrui Pharmaceutical Business Overview
    Table 137. Hengrui Pharmaceutical Targeted Drugs for Breast Cancer Product
    Table 138. Hengrui Pharmaceutical Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 139. Hengrui Pharmaceutical Recent Development
    Table 140. Beijing Biostar Technologies Company Details
    Table 141. Beijing Biostar Technologies Business Overview
    Table 142. Beijing Biostar Technologies Targeted Drugs for Breast Cancer Product
    Table 143. Beijing Biostar Technologies Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 144. Beijing Biostar Technologies Recent Development
    Table 145. Bayer Company Details
    Table 146. Bayer Business Overview
    Table 147. Bayer Targeted Drugs for Breast Cancer Product
    Table 148. Bayer Revenue in Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 149. Bayer Recent Development
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Targeted Drugs for Breast Cancer Product Picture
    Figure 2. Global Targeted Drugs for Breast Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Targeted Drugs for Breast Cancer Market Size 2017-2028 (US$ Million)
    Figure 4. United States Targeted Drugs for Breast Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Targeted Drugs for Breast Cancer Market Size 2017-2028 (US$ Million)
    Figure 6. United States Targeted Drugs for Breast Cancer Market Share in Global 2017-2028
    Figure 7. Targeted Drugs for Breast Cancer Report Years Considered
    Figure 8. Product Picture of HER-2 Targeted Drugs
    Figure 9. Product Picture of CDK4/6 Inhibitors
    Figure 10. Product Picture of PARP Targeted Drugs
    Figure 11. Product Picture of PI3K/AKT/mTor Pathway Inhibitors
    Figure 12. Product Picture of ER Targeted Drugs
    Figure 13. Product Picture of Aromatase Inhibitors
    Figure 14. Product Picture of Tubulin Inhibitors
    Figure 15. Product Picture of VEGF Targeted Drugs
    Figure 16. Product Picture of YTMS Targeted Drugs
    Figure 17. Product Picture of Other
    Figure 18. Global Targeted Drugs for Breast Cancer Market Share by Type in 2022 & 2028
    Figure 19. Global Targeted Drugs for Breast Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. Global Targeted Drugs for Breast Cancer Market Share by Type (2017-2028)
    Figure 21. United States Targeted Drugs for Breast Cancer Market Share by Type in 2022 & 2028
    Figure 22. United States Targeted Drugs for Breast Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 23. United States Targeted Drugs for Breast Cancer Market Share by Type (2017-2028)
    Figure 24. Product Picture of Hospital
    Figure 25. Product Picture of Clinic
    Figure 26. Product Picture of Drug Center
    Figure 27. Product Picture of Other
    Figure 28. Global Targeted Drugs for Breast Cancer Market Share by Application in 2022 & 2028
    Figure 29. Global Targeted Drugs for Breast Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. Global Targeted Drugs for Breast Cancer Market Share by Application (2017-2028)
    Figure 31. United States Targeted Drugs for Breast Cancer Market Share by Application in 2022 & 2028
    Figure 32. United States Targeted Drugs for Breast Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 33. United States Targeted Drugs for Breast Cancer Market Share by Application (2017-2028)
    Figure 34. North America Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. U.S. Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Canada Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Europe Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. Germany Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. France Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. U.K. Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Italy Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Russia Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Asia-Pacific Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 44. China Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Japan Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. South Korea Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. India Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Australia Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Taiwan Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Indonesia Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Thailand Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Malaysia Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Philippines Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Latin America Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Mexico Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Brazil Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Argentina Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Middle East & Africa Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 59. Turkey Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Saudi Arabia Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 61. U.A.E Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Roche Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 63. Teva Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 64. Mylan Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 65. Hikma Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 66. Hengrui Medicine Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 67. Cipla Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 68. Reliance Group Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 69. Hetero Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 70. Pfizer Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 71. Eli Lilly Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 72. Novartis Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 73. CANbridge Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 74. Puma Biotechnology Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 75. AstraZeneca Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 76. Chugai Pharmaceutical Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 77. Eisai Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 78. GlaxoSmithKline Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 79. Bristol-Myers Squibb Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 80. Otsuka Pharmaceutical Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 81. Merck Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 82. BioMarin Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 83. Hengrui Pharmaceutical Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 84. Beijing Biostar Technologies Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 85. Bayer Revenue Growth Rate in Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed